DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Arena Pharmaceuticals, Inc. (ARNA)
« Back to company indexARNA Chatter Timeline
Stock Ticker for ARNA
Most Active Tweeters for ARNA
| User | Tweets |
|---|---|
| @Tickeron | 14 |
| @Gambiste1 | 4 |
| @gcassidy718 | 4 |
| @OpenOutcrier | 2 |
| @deus_trader | 2 |
Recent Tweets for ARNA
 |
@Tickeron $ARNA's Aroon indicator reaches into Uptrend on March 27, 2020. View odds for this and other indicators:… https://t.co/uPhBNyzMdh April 9th 2020, 3:04pm |
|
@Tickeron $ARNA's Aroon indicator reaches into Uptrend on March 27, 2020. View odds for this and other indicators:… https://t.co/ci0R6v6fYQ April 8th 2020, 11:04am |
 |
@TalkMarkets Cannabis Central: How Well Do The Two New TSX Cannabis Indexes Track The Industry's Stock Performance? $CGC $ARNA… https://t.co/YLRkn1UQ4k April 7th 2020, 4:04pm |
 |
@JMLInvestments RT @SeekingAlpha: $ARNA - Arena Pharmaceuticals (ARNA) Investor Presentation - Slideshow. https://t.co/Elx1VByU04 #business #markets #econo… April 7th 2020, 4:04pm |
 |
@SeekingAlpha $ARNA - Arena Pharmaceuticals (ARNA) Investor Presentation - Slideshow. https://t.co/Elx1VByU04 #business #markets #economy April 7th 2020, 4:04pm |
|
@Tickeron $ARNA's Aroon indicator reaches into Uptrend on March 27, 2020. View odds for this and other indicators:… https://t.co/J0fRGXSvhO April 7th 2020, 12:04pm |
 |
@gcassidy718 $ARNA Would say I'm surprised, but I'm not. Will check ER. Might dabble again. Maybe. 4.46 % change recently https://t.co/5RGE4KUZhl April 6th 2020, 10:04pm |
|
@Tickeron $ARNA's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/Q7S3COMsNv April 6th 2020, 11:04am |
|
@Tickeron $ARNA's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/ziYBqCfWtA April 5th 2020, 11:04am |
 |
@A1Trades4U $ARNA from https://t.co/RfWl9yJKRP https://t.co/RT169UUS6a #bullish. Notes are in the chart. 20 day almost crossed… https://t.co/dBz9dRNyaX April 4th 2020, 11:04pm |
|
@Tickeron $ARNA's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/PPscmceSUq April 4th 2020, 12:04pm |
 |
@TranscriptDaily Arena Pharmaceuticals $ARNA Now Covered by Analysts at Guggenheim https://t.co/9ONNrVQbZK April 4th 2020, 8:04am |
 |
@WeekHerald Arena Pharmaceuticals $ARNA Now Covered by Analysts at Guggenheim https://t.co/AMCLNm5x4Q April 4th 2020, 8:04am |
 |
@dakotafinancial Arena Pharmaceuticals $ARNA Trading 8% Higher https://t.co/dBpjIniUqX April 4th 2020, 7:04am |
 |
@dailypoliticaln Arena Pharmaceuticals $ARNA Trading 8% Higher https://t.co/Tds4IcfLzl April 4th 2020, 7:04am |
 |
@EnterpriseLeade Arena Pharmaceuticals $ARNA Trading 8% Higher https://t.co/aBHC1ILel3 April 4th 2020, 7:04am |
 |
@MarcJacksonLA RT @MSollender: JPM 9 biotech picks (2/2): $ARNA - Strong balance sheet, good entry point for a busy 2H20/21 $UTHR - Commercial products… April 3rd 2020, 9:04pm |
 |
@SwingTradeBot Rose Above Upper Bollinger Band today: $ARNA $DNN ... https://t.co/AyIukUGmib April 3rd 2020, 3:04pm |
 |
@MSollender JPM 9 biotech picks (2/2): $ARNA - Strong balance sheet, good entry point for a busy 2H20/21 $UTHR - Commercial p… https://t.co/lRhdLXfHtH April 3rd 2020, 1:04pm |
|
@Tickeron $ARNA enters an Uptrend because Momentum Indicator exceeded the 0 level on March 25, 2020. View odds for this and o… https://t.co/7F8X5ohT9M April 3rd 2020, 12:04pm |
 |
@stocknewstimes Arena Pharmaceuticals $ARNA Research Coverage Started at Guggenheim https://t.co/hB2Q0sB5eo April 3rd 2020, 7:04am |
|
@EnterpriseLeade Guggenheim Initiates Coverage on Arena Pharmaceuticals $ARNA https://t.co/iBadtv4E4Z April 3rd 2020, 7:04am |
 |
@ConsumerFeed Arena Pharmaceuticals $ARNA Research Coverage Started at Guggenheim https://t.co/nBXXAPnKD3 April 3rd 2020, 7:04am |
 |
@BlueBioNow $ARNA might be worth taking a position when this bottoms 2.71 % change recently https://t.co/i2vzthav1u April 3rd 2020, 12:04am |
 |
@OlympiaReport Arena Pharmaceuticals $ARNA Research Coverage Started at Guggenheim https://t.co/K1XyKNj0zc April 2nd 2020, 6:04pm |
 |
@deus_trader Optimus v4 2020-04-02 15:55 EST. *Closed/Sold: $ARNA at $43.66 for 1.60 profit (3.80%). Arena Pharmaceuticals, Inc… https://t.co/EBUBfiq1zL April 2nd 2020, 4:04pm |
 |
@semodough $ARNA released top-line results from a ph1 trial evaluating a controlled-release (CR) delivery form of etrasimod. s… https://t.co/43LCY3QOms April 2nd 2020, 3:04pm |
|
@Tickeron $ARNA's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/WUKAL8eu8o April 2nd 2020, 12:04pm |
 |
@gregorypozo RT @OpenOutcrier: $ARNA (-0.3% pre) Arena Pharmaceuticals Announces Positive Topline Data for New Development Program - Etrasimod Controlle… April 2nd 2020, 8:04am |
 |
@OpenOutcrier $ARNA (-0.3% pre) Arena Pharmaceuticals Announces Positive Topline Data for New Development Program - Etrasimod Con… https://t.co/LaIJId8T2U April 2nd 2020, 8:04am |
 |
@HealthcareBeat Arena Pharma announces encouraging data on controlled-release etrasimod $ARNA https://t.co/AgTIZ0UHC5 April 2nd 2020, 4:04am |
 |
@Briefingcom $ARNA: Arena Pharm announces positive topline data from a Phase 1 clinical study for etrasimod https://t.co/y5eYwOPkSx April 1st 2020, 6:04pm |
 |
@Gambiste1 RT @RMPerry88: $ARNA out with “encouraging” data. Can’t decide just yet if that’s worse than “positive”. ? April 1st 2020, 5:04pm |
|
@Gambiste1 RT @Biohazard3737: When was the last time a company held a conference call to discuss PK data for an extended release formulation? $ARNA April 1st 2020, 5:04pm |
|
@Gambiste1 RT @Amp_Trades: $ARNA Arena Pharmaceuticals Announces Positive Topline Data for New Development Program - Etrasimod Controlled-Release (CR) April 1st 2020, 5:04pm |
 |
@RMPerry88 $ARNA out with “encouraging” data. Can’t decide just yet if that’s worse than “positive”. ? April 1st 2020, 5:04pm |
 |
@Biohazard3737 When was the last time a company held a conference call to discuss PK data for an extended release formulation? $ARNA April 1st 2020, 4:04pm |
 |
@path1finder $ARNA https://t.co/Norh7lETKm April 1st 2020, 4:04pm |
 |
@otcdynamics $ARNA Arena Pharmaceuticals Announces Positive Topline Data for New Development Program – Etrasimod C https://t.co/uGFVnRSpdg April 1st 2020, 4:04pm |
 |
@Stock_News_Now $ARNA: New SEC Filing for ARNA: Form 8-K (No. 0001564590-20-014775): https://t.co/fg9H174Y9W April 1st 2020, 4:04pm |
 |
@MarketCurrents $ARNA - Arena Pharma announces encouraging data on controlled-release etrasimod https://t.co/6Nh2hAFOBC April 1st 2020, 4:04pm |
 |
@fintel_io Also, if you are new to $ARNA here's a background article on Finpedia for you https://t.co/ji7KyJC7bB April 1st 2020, 4:04pm |
|
@fintel_io $ARNA / Arena Pharmaceuticals files form 8-K - Regulation FD Disclosure, Financial Statements and Exhibits, Other E… https://t.co/Obzp7s4NcY April 1st 2020, 4:04pm |
 |
@VisualStockRSRC $ARNA - Arena Pharmaceuticals Announces Positive Topline Data for New Development Program - Etrasimod https://t.co/0F9eeRkMDR April 1st 2020, 4:04pm |
 |
@Amp_Trades $ARNA Arena Pharmaceuticals Announces Positive Topline Data for New Development Program - Etrasimod Controlled-Release (CR) April 1st 2020, 4:04pm |
|
@Tickeron $ARNA's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram crosses above signal line. View odds for… https://t.co/sfEAEOfHnM April 1st 2020, 3:04pm |
|
@Tickeron $ARNA's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/PA2fiq6QG2 March 31st 2020, 1:03pm |
|
@biostockinfo RT @TomSilver39: Guggenheim:" $ARNA - Modulating GPCRs to Treat Inflammation and Pain From the GI to the Skin; Initiate with a BUY Rating a… March 31st 2020, 1:03pm |
 |
@TomSilver39 Guggenheim:" $ARNA - Modulating GPCRs to Treat Inflammation and Pain From the GI to the Skin; Initiate with a BUY Rating and $95 PT." March 31st 2020, 1:03pm |
 |
@eat2muchfood $ARNA Guggenheim Securities Initiates Coverage On Arena Pharmaceuticals with Buy Rating, Announces Price Target to $95 March 31st 2020, 12:03pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.